Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 2Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Psychological Well-Being 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Esophageal Neoplasms 1Cardiovascular Diseases 1

Interventions

pembrolizumab 223Carboplatin 217Cisplatin 205Paclitaxel 182Gemcitabine 149Docetaxel 127Capecitabine 114Dexamethasone 102Pemetrexed 101Cyclophosphamide 101Specimen Handling 99Magnetic Resonance Spectroscopy 97Oxaliplatin 96Radiotherapy 94Doxorubicin 90Fluorouracil 88Bevacizumab 83Nivolumab 74Leucovorin 73Rituximab 70durvalumab 66Vincristine 66Lenalidomide 64Irinotecan 61Etoposide 61atezolizumab 60Radiation 60130-nm albumin-bound paclitaxel 57Prednisone 56Letrozole 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Fish Oils × 1 year × Clear all
NCT04871412 2026-01-30

POISE

Ottawa Hospital Research Institute

Phase 3 Recruiting
20 enrolled
GastrointestinalThoracic

Psychological Well-Being, Esophageal Neoplasms, Lung Neoplasms, Motor Activity, Stomach Neoplasms

NCT01169259 2025-11-06

VITAL

Brigham and Women's Hospital

Phase 3 Active not recruiting
25,871 enrolled 38 charts

Cardiovascular Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡